Bosentan attenuates hypertensive effect of angiotensin II in the rat;Le bosentan attenue l'effet hypertenseur de l'angiotensine II chez le rat

Archives des Maladies du Coeur et des Vaisseaux

Volumn 90, Issue 8, 1997, Pages 1117-1120

  Herizi, A ^b   Jover, B ^b   Mimran, A ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; BOSENTAN; ANGIOTENSIN II; ENDOTHELIN; ENDOTHELIN RECEPTOR; SULFONAMIDE;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE THERAPY; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; HEART OUTPUT; HYPERTENSION; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; ANIMAL; BLOOD FLOW; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; DRUG INTERACTION; HEMODYNAMICS; KIDNEY CIRCULATION; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ENDOTHELINS; HEMODYNAMIC PROCESSES; HYPERTENSION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ENDOTHELIN; REGIONAL BLOOD FLOW; RENAL CIRCULATION; SULFONAMIDES;

EID: 0030608868     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Emori T, Hirata Y, Ohta K et al. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension 1991 ; 18 : 165-70.
2. Sung CP, Arleth AJ, Storer BL, Ohlstein EH. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle. J Pharmacol Exp Ther 1994 ; 271 : 429-37.
3. Dohi Y, Hahn AWA, Boulanger CM, Bühler FR, Lüscher TF. Endothelin stimulated by angtotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 1992 ; 19 : 131-7.
4. Yoshida K, Yasujima M, Kohzuki M, Kanazawa M, Yoshinaga K, Abe K. Endothelin-1 augments pressor response to angiotensin II infusion in rats. Hypertension 1992 ; 20 : 292-7.
5. Chen L, McNeill JR, Wilson TW, Gopalakrishnan V. Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels. Br J Pharmacol 1995 ; 114 : 1599-604.
6. Douglas SA, Gellai M, Ezekiel M, Ohlstein EH. BQ-23, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertension. J Hypertension 1994 ; 12 : 561-7.
7. Clozel M, Breu V, Gray GA et al. Pharmacological characterization of bosentan, a new potent orally active non peptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994 ; 270 : 228-35.
8. Krämer BK, Schricker K, Scholz H, Clozel M, Riegger GAJ, Kurtz A. Role of endothelins for renin regulation. Kidney Int 1996 ; 49, Suppl. 55 : S 119-S 121.
9. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992 ; 19 : 753-7.
10. Balakrishnon SM, Wang HD, Gopolakrishnan V, Wilson TW, McNeill JR. Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension 1996 ; 28 : 806-9.